- Home
- RAYA vs INKT Comparison
RAYA vs INKT Comparison
Compare RAYA & INKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RAYA
- INKT
- Stock Information
- Founded
- RAYA 2019
- INKT 2017
- Country
- RAYA China
- INKT United States
- Employees
- RAYA N/A
- INKT N/A
- Industry
- RAYA Metal Fabrications
- INKT Medicinal Chemicals and Botanical Products
- Sector
- RAYA Consumer Discretionary
- INKT Health Care
- Exchange
- RAYA Nasdaq
- INKT Nasdaq
- Market Cap
- RAYA 89.2M
- INKT 28.9M
- IPO Year
- RAYA 2022
- INKT 2021
- Fundamental
- Price
- RAYA $2.60
- INKT $7.04
- Analyst Decision
- RAYA
- INKT Strong Buy
- Analyst Count
- RAYA 0
- INKT 2
- Target Price
- RAYA N/A
- INKT $37.50
- AVG Volume (30 Days)
- RAYA 186.9K
- INKT 14.7K
- Earning Date
- RAYA 01-01-0001
- INKT 08-12-2025
- Dividend Yield
- RAYA N/A
- INKT N/A
- EPS Growth
- RAYA N/A
- INKT N/A
- EPS
- RAYA N/A
- INKT N/A
- Revenue
- RAYA $30,300,360.00
- INKT N/A
- Revenue This Year
- RAYA $20.95
- INKT N/A
- Revenue Next Year
- RAYA N/A
- INKT N/A
- P/E Ratio
- RAYA N/A
- INKT N/A
- Revenue Growth
- RAYA 49.10
- INKT N/A
- 52 Week Low
- RAYA $0.56
- INKT $4.56
- 52 Week High
- RAYA $2.88
- INKT $13.79
- Technical
- Relative Strength Index (RSI)
- RAYA 68.12
- INKT 47.56
- Support Level
- RAYA $1.94
- INKT $6.91
- Resistance Level
- RAYA $2.88
- INKT $7.51
- Average True Range (ATR)
- RAYA 0.32
- INKT 0.32
- MACD
- RAYA 0.03
- INKT -0.02
- Stochastic Oscillator
- RAYA 77.05
- INKT 27.28
About RAYA Erayak Power Solution Group Inc.
Erayak Power Solution Group Inc engages in manufacturing, research and development, and wholesale and retail of power solution products. Its product portfolio includes sine wave and off-grid inverters, inverter and gasoline generators, battery, and smart chargers, and custom-designed products. It derives the majority revenue from four products namely inverters, chargers, power bank, and gasoline generators. The company generates the majority of its revenue from Inverters. The company geographically operates in China, Australia, Poland, U.K., and Germany. It derives maximum revenue from China.
About INKT MiNK Therapeutics Inc.
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. The company is advancing a pipeline of both native and next generation engineered iNKT programs, with a platform designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery.